Beckman Coulter Announces Management Change.Business Editors/Health/Medical Writers FULLERTON, Calif.--(BUSINESS WIRE)--Aug. 6, 2003 Beckman Coulter This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. , Inc. (NYSE NYSE See: New York Stock Exchange :BEC) today announced that Amin I. Khalifa, vice president, Finance and Chief Financial Officer (CFO See Chief Financial Officer. ), will leave the company, effective August 8, 2003, to pursue other opportunities. Beckman Coulter's Vice President, Controller & Chief Accounting Officer, James T. Glover, will serve as interim CFO. "In the four years that I have been with Beckman Coulter, the company has changed considerably, substantially reducing debt and improving operating margins Operating Margin A ratio used to measure a company's pricing strategy and operating efficiency. Calculated by: . I am proud of our accomplishments," said Khalifa. "With the company in a strong financial position, it is an ideal time for me to explore other opportunities." Beckman Coulter, Inc. is a leading manufacturer of instrument systems, chemistries and supplies that simplify and automate laboratory processes. At the forefront of medical discovery, in clinical research and through the often life-saving process of clinical diagnostics, Beckman Coulter's 200,000 installed systems provide essential biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. intelligence to enhance health care around the world. The company, based in Fullerton, Calif., reported 2002 annual sales of $2.06 billion with 62 percent of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit www.beckmancoulter.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion